IBELNIA

pharmaceuticals, namely, oral contraceptives; oral hormonal contraceptives; contraceptive preparations; hormone replacement therapy preparations; hormonal agents for treating disorders and conditions related to women's health, namely, symptoms and conditions associated with menopause, pre-menstruation syndrome and other symptoms and conditions associated with menstruation; transdermal patches featuring contraceptive preparations